Kojic Acid
5-Hydroxy-2-(hydroxymethyl)-4H-pyrane-4-one
Kojic Acid 列于附件 III,只能在本记录所示条件下使用。 本记录中的最大浓度:1 %。
如何阅读本条目
Kojic acid became a restricted substance in 2024: 1% in face and hand products, and nowhere else. Two deadlines in 2025 close the transition from either end of the supply chain.
- 1%, and only in face and hand products.
- Body products, hair products and everything else are outside the permitted product types.
- 1 February 2025 stops non-compliant products being placed on the market.
- 1 November 2025 stops them being made available, which reaches stock already with distributors and retailers.
The concentration is the part that gets quoted and the product-type condition is the part that decides most cases. Kojic acid may be used at up to 1%, and only in face and hand products. A body serum at 0.5% is not a conservative reading of this entry; it is outside it, because the product type is not among the permitted ones.
Regulation (EU) 2024/996 introduced the restriction, and the two dates do different jobs. From 1 February 2025 a non-compliant product may not be placed on the Union market — the first supply by a manufacturer or importer. From 1 November 2025 it may not be made available, which covers onward sale by anyone holding stock. A product lawfully placed before February could still be sold until November, and not after.
核对依据
记录详情
最大浓度
1 %
其他限制
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.
INCI 词汇表名称
Kojic Acid
化学名称
5-Hydroxy-2-(hydroxymethyl)-4H-pyrane-4-one
监管信息
关键数据
化学身份与性质

Kojic Acid
Kojic acid is a pyranone that is 4H-pyran substituted by a hydroxy group at position 5, a hydroxymethyl group at position 2 and an oxo group at position 4. It has been isolated from the fungus Aspergillus oryzae. It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor, a NF-kappaB inhibitor, an Aspergillus metabolite, a skin lightening agent, an EC 1.10.3.1 (catechol oxidase) inhibitor, an EC 1.10.3.2 (laccase) inhibitor, an EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor and an EC 1.4.3.3 (D-amino-acid oxidase) inhibitor. It is a member of 4-pyranones, a primary alcohol and an enol. It derives from a hydride of a 4H-pyran. — ChEBI
- IUPAC 名称
- 5-hydroxy-2-(hydroxymethyl)pyran-4-one
- 分子式
- C6H6O4
- 分子量
- 142.11 g/mol
- 精确质量
- 142.02660867 Da
- XLogP3
- -0.9
- 拓扑极性表面积
- 66.8 Ų
- 氢键供体
- 2
- 氢键受体
- 4
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:43572
- ChEMBL:CHEMBL287556
- EPA DTXSID:DTXSID2040236
- PubMed:23353126
- PubMed:23091364
- PubMed:23089353
- PubMed:23063404
- PubMed:23054709
- PubMed:23016291
- PubMed:23007519
- PubMed:22952594
- PubMed:22939001
- PubMed:22926028
- PubMed:22909023
- PubMed:22905751
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
Kojic Acid 的清单链接
Kojic Acid 的相关记录
该记录的直接匹配结果有限,因此同时显示附件 III 中的相邻条目。
Retinol; Retinyl Acetate; Retinyl Palmitate
Pinene
附件 III 对 Kojic Acid 意味着什么
Kojic Acid 是欧盟化妆品法规 1223/2009 附件 III 中的限用物质。其在化妆品中的使用仅限于上方条目所列的特定条件,包括适用的浓度限值、产品类型限制和必须标示的警示语。
在配方中使用该物质时,必须同时满足所有条件——最大浓度、产品范围和警示标签。满足其中一项条件并不能免除其他条件。
本记录与 1 个 CosIng 清单成分相关联,便于名称和标识符的交叉引用。 本页还显示 12 条相关附件记录,其标识符、附件逻辑或命名模式存在重叠。
合规核查清单
- 确保配方浓度不超过:1 %
- 确认产品类型相符:Face and hand products
- 将使用条件记录在产品信息档案 (PIF) 中。